Abstract
Background Celiac disease, a gluten-triggered autoimmune disorder, is known for its systemic inflammatory effects. Epidemiological data suggest an association with type 2 inflammatory diseases like asthma, allergic rhinitis, and atopic dermatitis, however, genetic associations remain unclear, prompting this study to explore their potential genetic interplay.
Methods Utilizing Two-Sample Mendelian Randomization (TSMR), we examined genetic associations using 15 genetic instruments from GWAS datasets. Our analysis focused on celiac disease and its relation to asthma, allergic rhinitis, and atopic dermatitis. Power analysis was conducted to determine the study’s detection capabilities, and Odds Ratios (ORs) with 95% confidence intervals (CIs) were calculated using various MR methods.
Results A significant positive association was observed between celiac disease and atopic dermatitis (OR = 1.037, 95% CI: 1.015 - 1.059), and a slight association with allergic rhinitis (OR = 1.002, 95% CI: 1.0004 - 1.0032). Conversely, a minor protective effect was noted for asthma (OR = 0.97, 95% CI: 0.96 - 0.98). These results, supported by a high F-statistic, suggest a strong genetic linkage, despite some heterogeneity and complexity in the associations.
Conclusion Our study identifies significant genetic links between celiac disease and type 2 inflammatory diseases, particularly atopic dermatitis and allergic rhinitis, with a minor protective effect against asthma. These findings, underscored by a strong F-statistic, suggest complex genetic interactions and emphasize the need for further research to explore their clinical relevance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
GWAS data base
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial disclosure – none
Data Availability
All data produced in the present study are available upon reasonable request to the authors
